Association of liver cirrhosis related IgA nephropathy with portal hypertension

World Journal of Gastroenterology

Volumn 13, Issue 43, 2007, Pages 5783-5786

  Kalambokis, Georgios ^a   Christou, Leonidas ^a   Stefanou, Dimitrios ^a   Arkoumani, Evdokia ^a   Tsianos, Epameinondas V ^a,b  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

IIgA nephropathy; Liver cirrhosis; Nephrotic syndrome; Portal hypertension

Indexed keywords

ACENOCOUMAROL; ALANINE AMINOTRANSFERASE; ANTICOAGULANT AGENT; CREATININE; FERRITIN; FUROSEMIDE; IMMUNOGLOBULIN A; PROPRANOLOL; PROTEIN; SPIRONOLACTONE;

ABDOMINAL DISTENSION; ADULT; ANKLE EDEMA; ARTICLE; ASCITES; CASE REPORT; COLONOSCOPY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; ECHOGRAPHY; HEMATURIA; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER CLEARANCE; MALE; NEPHROTIC SYNDROME; OCCULT BLOOD; PERIORBITAL EDEMA; POLYMERASE CHAIN REACTION; PORTAL HYPERTENSION; PROTEINURIA; SPLENIC VEIN; VEIN THROMBOSIS;

EID: 36248962170     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i43.5783     Document Type: Article

References (40)

1. Newell GC. Cirrhotic glomerulonephritis: incidence, morphology, clinical features, and pathogenesis. Am J Kidney Dis 1987; 9:183-190
2. Sinniah R. Heterogeneous IgA glomerulonephropathy in liver cirrhosis. Histopathology 1984; 8: 947-962
3. Endo Y, Matsushita H, Nozawa Y, Nishikage S, Matsuya S, Hara M. Glomerulonephritis associated with liver cirrhosis. Acta Pathol Jpn 1983; 33: 333-346
4. Iida H, Izumino K, Matsumoto M, Takata M, Mizumura Y, Sugimoto T. Glomerular deposition of IgA in experimental hepatic cirrhosis. Acta Pathol Jpn 1985; 35: 561-567
5. Sancho J, Egido J, Sanchez-Crespo M, Blasco R. Detection of monomeric and polymeric IgA containing immune complexes in serum and kidney from patients with alcoholic liver disease. Clin Exp Immunol 1982; 47: 327-335
6. Lai KN, Lai FM, Tam JS, Vallance-Owen J. Strong association between IgA nephropathy and hepatitis B surface antigenemia in endemic areas. Clin Nephrol 1988; 29: 229-234
7. Couser WG. Glomerulonephritis. Lancet 1999; 353: 1509-1515
8. Cecchin E, De Marchi S. Alcohol misuse and renal damage. Addict Biol 1996; 1: 7-17
9. Singri N, Gleason B, Flamm SL, Kanwar YS, Ghossein C. Secondary IgA nephropathy presenting as nephrotic syndrome with glomerular crescentic changes and acute renal failure in a patient with autoimmune hepatitis. J Nephrol 2004; 17: 125-129
10. Gouet D, Fort E, Roblot P, Marechaud R, Sudre Y, Touchard G. Glomerulopathy with mesangial IgA deposits in primary hemochromatosis. Rev Med Interne 1987; 8: 311-312
11. Szonyi L, Dobos M, Vasarhelyi B, Heninger E, Vas T, Nagy J, Kovacs T. Prevalence of alphal-antitrypsin phenotypes in patients with IgA nephropathy. Clin Nephrol 2004; 62: 418-422
12. Pouria S, Feehally J. Glomerular IgA deposition in liver disease. Nephrol Dial Transplant 1999; 14: 2279-2282
13. Coppo R, Arico S, Piccoli G, Basolo B, Roccatello D, Amore A, Tabone M, De la Pierre M, Sessa A, Delacroix DL. Presence and origin of IgA1- and IgA2-containing circulating immune complexes in chronic alcoholic liver diseases with and without glomerulonephritis. Clin Immunol Immunopathol 1985; 35: 1-8
14. Nochy D, Callard P, Bellon B, Bariety J, Druet P. Association of overt glomerulonephritis and liver disease: a study of 34 patients. Clin Nephrol 1976; 6:422-427
15. Rifai A, Fadden K, Morrison SL, Chintalacharuvu KR. The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA.2 isotypes. J Exp Med 2000; 191: 2171-2182
16. Delacroix DL, Elkom KB, Geubel AP, Hodgson HF, Dive C, Vaerman JP. Changes in size, subclass, and metabolic properties of serum immunoglobulin A in liver diseases and in other diseases with high serum immunoglobulin A. J Clin Invest 1983; 71: 358-367
17. Finck MH, Reichen J, Vierling JM, Kloppel TM, Brown WR. Hepatic uptake and disposition of human polymeric IgA1 in perfused rat liver: evidence for incomplete biliary excretion and intrahepatic degradation. Am J Physiol 1985; 248: G450-G455
18. Rifai A, Mannik M. Clearance of circulating IgA immune complexes is mediated by a specific receptor on Kupffer cells in mice. J Exp Med 1984; 160: 125-137
19. Lomax-Smith JD, Zabrowarny LA, Howarth GS, Seymour AE, Woodroffe AJ. The immunochemical characterization of mesangial IgA deposits. Am J Pathol 1983; 113: 359-364
20. Nakamoto Y, Iida H, Kobayashi K, Dohi K, Kida H, Hattori N, Takeuchi J. Hepatic glomerulonephritis. Characteristics of hepatic IgA glomerulonephritis as the major part. Virchows Arch A Pathol Anat Histol 1981; 392: 45-54
21. Ohashi K, Orihata G, Ohta S, Takamori S, Kojima K, Fukazawa M, Beppu T, Futagawa S. Portal hypertensive gastropathy and colopathy. Nippon Rinsho 1998; 56: 2369-2375
22. Lebrec D, Hillon P, Munoz C, Goldfarb G, Nouel O, Benhamou JP. The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study. Hepatology 1982; 2: 523-527
23. Henriksen JH, Ring-Larsen H. Renal effects of drugs used in the treatment of portal hypertension. Hepatology 1993; 18: 688-695
24. Evans GR, Yellin AE, Weaver FA, Stain SC. Sinistral (left-sided) portal hypertension. Am Surg 1990; 56: 758-763
25. Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS, Hillarp A, Watzke HH, Bernardi F, Cumming AM, Preston FE, Reitsma PH. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998; 79: 706-708
26. Sagripanti A, Barsotti G. Hypercoagulability, intraglomerular coagulation, and thromboembolism in nephrotic syndrome. Nephron 1995; 70: 271-281
27. Carrion JA, Bellot P, Colmenero J, Garcia Pagan JC. Large spontaneous splenorenal shunt as a cause of chronic hepatic encephalopathy. J Hepatol 2004; 40: 868
28. Nakamura M, Ohishi A, Watanabe R, Kaneko K, Aosaki N, Iigaya T, Monma T, Sugiura H, Miyoshi Y, Hamaguchi K. IgA nephropathy associated with portal hypertension in liver cirrhosis due to non-alcoholic and non-A, non-B, non-C hepatitis. Intern Med 1994; 33: 488-491
29. Laurent J, Lagrue G, Bruneau. C, Kazandjian M. Does portal hypertension play a role in IgA mesangial glomerulonephritis (IgG GN)? Kidney Int 1986; 30: 640 (Abstract)
30. Babbs C, Warnes TW, Torrance HB, Ballardie FW. IgA nephropathy in non-cirrhotic portal hypertension. Gut 1991; 32: 225-226
31. Gunnarsdottir SA, Sadik R, Shev S, Simren M, Sjovall H, Stotzer PO, Abrahamsson H, Olsson R, Bjornsson ES. Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension. Am J Gastroenterol 2003; 98: 1362-1370
32. Reilly JA Jr, Quigley EM, Forst CF, Rikkers LF. Small intestinal transit in the portal hypertensive rat. Gastroenterology 1991; 100: 670-674
33. Yao GX, Shen ZY, Xue XB, Yang Z. Intestinal permeability in rats with CC14-induced portal hypertension. World J Gastroenterol 2006; 12: 479-481
34. Macpherson AJ. IgA adaptation to the presence of commensal bacteria in the intestine. Curr Top Microbiol Immunol 2006; 308: 117-136
35. Woodroffe AJ, Gormly AA, McKenzie PE, Wootton AM, Thompson AJ, Seymour AE, Clarkson AR. Immunologic studies in IgA nephropathy. Kidney Int 1980; 18: 366-374
36. Lumsden AB, Henderson JM, Kutner MH. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 1988; 8: 232-236
37. Chiva M, Guarner C, Peralta C, Llovet T, Gomez G, Soriano G, Balanzo J. Intestinal mucosal oxidative damage and bacterial translocation in cirrhotic rats. Eur J Gastroenterol Hepatol 2003; 15: 145-150
38. Albillos A, de la Hera A, Gonzalez M, Moya JL, Calleja JL, Monserrat J, Ruiz-del-Arbol L, Alvarez-Mon M. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 2003; 37: 208-217
39. Leveille-Webster CR, Rogers J, Arias IM. Use of an asialoglycoprotein receptor-targeted magnetic resonance contrast agent to study changes in receptor biology during liver regeneration and endotoxemia in rats. Hepatology 1996; 23: 1631-1641
40. Perez-Paramo M, Munoz J, Albillos A, Freile I, Portero F, Santos M, Ortiz-Berrocal J. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. Hepatology 2000; 31: 43-48